My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Lunai Bioworks Inc. - Common Stock
(NQ:
RENB
)
1.420
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 30, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.420
Bid (Size)
1.530 (5)
Ask (Size)
1.540 (48)
Prev. Close
1.420
Today's Range
1.420 - 1.420
52wk Range
1.214 - 21.00
Shares Outstanding
231,802,470
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
These stocks are moving in today's after hours session
October 01, 2025
The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
September 25, 2025
Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outstanding shares is at $87.2 million.
Via
Benzinga
Performance
YTD
-81.4%
-81.4%
1 Month
-22.4%
-22.4%
3 Month
-54.9%
-54.9%
6 Month
-59.7%
-59.7%
1 Year
-84.8%
-84.8%
More News
Read More
Gapping stocks in Thursday's session
September 25, 2025
Via
Chartmill
Top movers in Thursday's pre-market session
September 25, 2025
Via
Chartmill
Lunai Bioworks Advances Biomarker Discovery Preclinical Program in Parkinson's Disease, Positioning for Strategic Pharma Partnerships
September 25, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 25, 2025
Via
Benzinga
Why PepGen Shares Are Trading Higher By 112%; Here Are 20 Stocks Moving Premarket
September 25, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 24, 2025
Via
Benzinga
Top movers in Wednesday's after hours session
September 24, 2025
Via
Chartmill
Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split
September 24, 2025
Via
ACCESS Newswire
Lunai Bioworks subsidiary BioSymetrics and Brigham and Women’s Hospital Awarded NIH STTR Grant to Develop AI-Powered Platform for Alcohol Use Disorder Therapeutics
September 11, 2025
Via
ACCESS Newswire
Top 3 Health Care Stocks You'll Regret Missing In Q3
September 09, 2025
Via
Benzinga
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery
September 09, 2025
Via
ACCESS Newswire
Lunai Bioworks Strengthens European Strategy Through Restructuring
September 08, 2025
Via
ACCESS Newswire
Lunai Bioworks Inc. Retains American Defense International
September 04, 2025
Via
ACCESS Newswire
Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics
August 27, 2025
Via
ACCESS Newswire
PREDICTIVE ONCOLOGY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI
August 19, 2025
From
Kahn Swick & Foti, LLC
Via
GlobeNewswire
Renovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks
August 08, 2025
Via
ACCESS Newswire
Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector
July 28, 2025
Via
ACCESS Newswire
Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy
July 17, 2025
Via
ACCESS Newswire
Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives
July 09, 2025
Via
ACCESS Newswire
These stocks are moving in today's after hours session
June 30, 2025
Via
Chartmill
Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs
June 30, 2025
Via
ACCESS Newswire
Tuesday's session: gap up and gap down stocks
June 03, 2025
Via
Chartmill
Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform
June 03, 2025
From
Renovaro Inc
Via
GlobeNewswire
Frequently Asked Questions
Is Lunai Bioworks Inc. - Common Stock publicly traded?
Yes, Lunai Bioworks Inc. - Common Stock is publicly traded.
What exchange does Lunai Bioworks Inc. - Common Stock trade on?
Lunai Bioworks Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lunai Bioworks Inc. - Common Stock?
The ticker symbol for Lunai Bioworks Inc. - Common Stock is RENB on the Nasdaq Stock Market
What is the current price of Lunai Bioworks Inc. - Common Stock?
The current price of Lunai Bioworks Inc. - Common Stock is 1.420
When was Lunai Bioworks Inc. - Common Stock last traded?
The last trade of Lunai Bioworks Inc. - Common Stock was at 09/30/25 04:00 PM ET
What is the market capitalization of Lunai Bioworks Inc. - Common Stock?
The market capitalization of Lunai Bioworks Inc. - Common Stock is 329.16M
How many shares of Lunai Bioworks Inc. - Common Stock are outstanding?
Lunai Bioworks Inc. - Common Stock has 329M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.